Fibrínolysís parameters: Plasmin-α2 antíplasmin complexes (PAP) and D-dimers in acute coronary syndromes without ST segment elevation;Parametry układu fibrynolizy: Kompleksy plazmina-α2 antyplazmina oraz d-dimery w ostrych zespołach wieńcowych bez uniesienia odcinka ST

Polski Merkuriusz Lekarski

Volumn 17, Issue 102, 2004, Pages 555-557

  Grabarczyk, Ewa ^a,c   Wodyńska, Teresa ^b   Kotschy, Maria ^a  

^a Kat I Zaklad Patofizjologii A ^*  (Poland)

^b Kat I Klinika Kardiologii I C

^c Kat I Zaklad Patofizjologii A   (Poland)

Author keywords

Acute coronary syndrome without ST segment elevation; D dimers; Plasmin 2 antiplasmin complexes

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; PLASMIN;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC KIT; FEMALE; FIBRINOLYSIS; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SMOKING; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; AGED; ANTIPLASMIN; CORONARY DISEASE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYTIC AGENTS; HEART RATE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PLASMIN;

EID: 11844266526     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bayes-Genis A. i wsp.: Elevated levels of plasmin-alfa-2-antiplasmin complexes in unstable angina. Thromb. Haemost., 1999, 81, 865-868.
2. Cadroy Y. i wsp.: Influence of aging on the activity of coagulation system: prothrombin fragment 1+2, thrombin-antithrombin III complex and D-dimer healthy subjects with age ranging from 20 to 94 years. Nouv. Rev. Fr. Hematol., 1992, 34, 43-46.
3. Figueras J. i wsp.: Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest. J. Am. Coll. Cardiol., 2000, 36, 7, 2036-2043.
4. Feinberg W.M. i wsp.: Plasmin-alfa-2 antiplasmin complex in patients with atrial fibrillation. Thromb. Heamost., 1999, 82, 100-103.
5. Grundmann U. i wsp.: Cardiovascular effects of desflurane and isoflurane in patients with coronary artery disease. Acta Anaesthesiol. Scand., 1996, 40, 1101-1107.
6. Jastrzȩbska M.: Znaczenie d-dimerów w diagnostyce zaburzeń hemostazy, Diagn. Lab., 1999, 35, 275-285.
7. Knight C.J.: New insight into the pathophysiology of acute coronary occlusion. Eur. Heart. J., 1999, 1, suppl. A, 3-6.
8. Kruskal J.B. i wsp.: Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N. Engl. J. Med., 1987, 317, 1361-135.
9. Lowe G.D.O. i wsp.: Fibrin d-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the caerphillly study. Thromb. Haemost., 1998, 79, 129-133.
10. Strano A. i wsp.: Plasma levels of the markers of coagulation and fibrinolysis arterial disease. Semin. Thromb. Hemost., 1996, 23, suppl. 1, 35.
11. Tataru M.C. i wsp.: D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur. Heart. J., 1999, 20, 1493-1502.
12. Wiman B. i wsp.: Plasmin/alfa 2-antiplasmin complex in plasma-a global fibrinolytic assay. Thromb. Haemost., 1993, 69, 1091-1094.
13. Vaziri N.D. i wsp.: Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Am. J. Med., 1992, 93, 651-657.
14. Yarnell Y.W.G. i wsp.: Lifestyle and hemostatic risk factors for ischemic heart disease. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 271-279.
15. Zawilska K.: Postȩpy w diagnostyce wewna̧trznaczyniowej aktywacji fibrynolizy. Acta Haematol. Pol., 1995, 26, 1, 33-36.